mRNA-4157,Pembrolizumab
Moderna,Merck
['merck', 'moderna']
18april: and present positive data for personalized #cancer vaccine. read this and other news from #aacr2023 in : 
Senior Business Editor, Genetic Engineering & Biotechnology News, GEN Edge, and Mary Ann Liebert Inc., New Rochelle, NY. https://t.co/b3rRmjLrzs